UMMS Affiliation

Commonwealth Medicine, Clinical Pharmacy Services

Publication Date

2011-08-12

Document Type

Technical Report

Disciplines

Health Services Administration | Health Services Research | Pharmacy and Pharmaceutical Sciences

Abstract

Pipeline PredictorRx™ evaluates new drugs, expected to have a significant clinical or financial impact when approved by the FDA, and compares them to current therapies.

This UMass Medical School model, entirely independent of drug company interests, goes beyond detailing pharmacy outcomes for pipeline drugs — we also examine the potential for avoiding hospitalization and other medical costs.

Keywords

Pipeline PredictorRx™, drug evaluation, drug impact, pipeline drugs

Journal/Book/Conference Title

Commonwealth Medicine Publications

Share

COinS